CTSOVSJAGX• 12 Months (Normalized)
CTSO vs JAGX (Cytosorbents Corporation vs Jaguar Health Inc.)
Showing Closing Date Range from Sep 25, 2025 to Sep 25, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CTSO Performance $4.91
+%
Cytosorbents Corporation
Normalized Baseline0.00%
JAGX Performance $7.06
-99.34%
Jaguar Health Inc.
Normalized Baseline0.00%
Alpha Spread Margin CTSO LEADS
+99.34 pts
CTSO outperforming by 99.34 percentage points
CTSOJAGX
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CTSO JAGX
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(251 dates)
| Date | CTSO Price | CTSO Gain (%) | JAGX Price | JAGX Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 24, 2026 | $- | $7.06 | -99.34% | - | |
| Sep 23, 2026 | $4.91 | +430.24% | $8.91 | -99.17% | +529.41% |
| Sep 22, 2026 | $- | $34.46 | -96.80% | - | |
| Sep 21, 2026 | $5.51 | +495.03% | $2.67 | -99.75% | +594.78% |
| Sep 18, 2026 | $5.75 | +520.95% | $2.71 | -99.75% | +620.70% |
| Sep 17, 2026 | $5.76 | +522.03% | $2.75 | -99.74% | +621.77% |
| Sep 16, 2026 | $5.73 | +518.79% | $3.50 | -99.68% | +618.47% |
| Sep 15, 2026 | $6.06 | +554.43% | $3.38 | -99.69% | +654.12% |
| Sep 14, 2026 | $6.07 | +555.51% | $0.32 | -99.97% | +655.48% |
| Sep 11, 2026 | $6.41 | +592.22% | $4.71 | -99.56% | +691.78% |
| Sep 10, 2026 | $6.37 | +587.90% | $4.79 | -99.56% | +687.46% |
| Sep 09, 2026 | $6.33 | +583.59% | $5.49 | -99.49% | +683.08% |
| Sep 08, 2026 | $- | $6.21 | -99.42% | - | |
| Sep 04, 2026 | $0.35 | -62.20% | $8.96 | -99.17% | +36.97% |
| Sep 03, 2026 | $0.35 | -62.20% | $10.41 | -99.03% | +36.83% |
Page 1 of 17